These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19147603)

  • 1. Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease.
    Pons D; de Vries FR; van den Elsen PJ; Heijmans BT; Quax PH; Jukema JW
    Eur Heart J; 2009 Feb; 30(3):266-77. PubMed ID: 19147603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
    Mai A; Altucci L
    Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal histone acetylase and deacetylase expression and function in lung inflammation.
    Adcock IM; Lee KY
    Inflamm Res; 2006 Aug; 55(8):311-21. PubMed ID: 16977378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulators and histone modification.
    Imhof A
    Brief Funct Genomic Proteomic; 2006 Sep; 5(3):222-7. PubMed ID: 16951415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible acetylation of non histone proteins: role in cellular function and disease.
    Batta K; Das C; Gadad S; Shandilya J; Kundu TK
    Subcell Biochem; 2007; 41():193-212. PubMed ID: 17484129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic alterations and cancer: new targets for therapy.
    Allen A
    IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation.
    Bäckdahl L; Bushell A; Beck S
    Int J Biochem Cell Biol; 2009 Jan; 41(1):176-84. PubMed ID: 18793748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin-remodelling mechanisms in cancer.
    Lafon-Hughes L; Di Tomaso MV; Méndez-Acuña L; Martínez-López W
    Mutat Res; 2008; 658(3):191-214. PubMed ID: 18403253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.
    Minucci S; Pelicci PG
    Nat Rev Cancer; 2006 Jan; 6(1):38-51. PubMed ID: 16397526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of cardiovascular differentiation.
    Ohtani K; Dimmeler S
    Cardiovasc Res; 2011 Jun; 90(3):404-12. PubMed ID: 21372004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylation of non-histone proteins modulates cellular signalling at multiple levels.
    Spange S; Wagner T; Heinzel T; Krämer OH
    Int J Biochem Cell Biol; 2009 Jan; 41(1):185-98. PubMed ID: 18804549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epigenetic bottleneck of neurodegenerative and psychiatric diseases.
    Sananbenesi F; Fischer A
    Biol Chem; 2009 Nov; 390(11):1145-53. PubMed ID: 19747081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic chromatin modifiers in barley: I. Cloning, mapping and expression analysis of the plant specific HD2 family of histone deacetylases from barley, during seed development and after hormonal treatment.
    Demetriou K; Kapazoglou A; Tondelli A; Francia E; Stanca MA; Bladenopoulos K; Tsaftaris AS
    Physiol Plant; 2009 Jul; 136(3):358-68. PubMed ID: 19470089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylases modulate vascular smooth muscle cell migration induced by cyclic mechanical strain.
    Yan ZQ; Yao QP; Zhang ML; Qi YX; Guo ZY; Shen BR; Jiang ZL
    J Biomech; 2009 May; 42(7):945-8. PubMed ID: 19261284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epigenetic conductor: a genomic orchestrator in chronic kidney disease complications?
    Ekström TJ; Stenvinkel P
    J Nephrol; 2009; 22(4):442-9. PubMed ID: 19662598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of epigenetics in the actions of alcohol.
    Shukla SD; Velazquez J; French SW; Lu SC; Ticku MK; Zakhari S
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1525-34. PubMed ID: 18616668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of vascular smooth muscle cell function in atherosclerosis.
    Findeisen HM; Kahles FK; Bruemmer D
    Curr Atheroscler Rep; 2013 Apr; 15(4):319. PubMed ID: 23423526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy.
    Lunke S; El-Osta A
    J Neurochem; 2009 Jun; 109(6):1557-69. PubMed ID: 19383090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm.
    Krishna SM; Dear AE; Norman PE; Golledge J
    Atherosclerosis; 2010 Sep; 212(1):16-29. PubMed ID: 20347091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease.
    Martino DJ; Prescott SL
    Allergy; 2010 Jan; 65(1):7-15. PubMed ID: 19796189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.